Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04795167 · ClinicalTrials.gov registry record

FlowTriever for Acute Massive Pulmonary Embolism (FLAME)

A clinical trial, sponsored by Inari Medical.

Completed
Registry status
115
Enrollment target

NCT04795167 is a clinical trial that has completed, run by Inari Medical. The registered enrollment target is 115 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04795167 has completed, sponsored by Inari Medical.

COMPLETED
Registry status
115 participants
Enrollment target

Study Summary

To evaluate treatment outcomes of patients diagnosed with high-risk (massive) pulmonary embolism

Trial Details

FieldValue
Enrollment Target 115 participants
Start Date 2021-03-16
Est. Completion 2022-12-19

Sponsor

Inari Medical

12 total trials

What the Registry Record Tells You About NCT04795167

The ClinicalTrials.gov registry entry for NCT04795167 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 115 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Inari Medical, which has 12 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT04795167 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04795167 about?

NCT04795167 is a clinical study titled "FlowTriever for Acute Massive Pulmonary Embolism (FLAME)". To evaluate treatment outcomes of patients diagnosed with high-risk (massive) pulmonary embolism

What is the current status of trial NCT04795167?

This trial is currently completed. The enrollment target is 115 participants. The study started on 2021-03-16. Estimated completion is 2022-12-19.

Who is sponsoring clinical trial NCT04795167?

This trial is sponsored by Inari Medical, which has 12 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.